LON:BIOG

The Biotech Growth Trust Final Earnings Results & Report

The Biotech Growth Trust logo
GBX 1,354 +16.00 (+1.20%)
As of 12:28 PM Eastern

The Biotech Growth Trust reported Final earnings on June 3, 2026. The company reported EPS of -GBX 1.90, while revenue was £430 thousand.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

The Biotech Growth Trust EPS Results

Actual EPS
-GBX 1.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

The Biotech Growth Trust Revenue Results

Actual Revenue
£430 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

The Biotech Growth Trust Final Earnings FAQ

The Biotech Growth Trust (LON:BIOG) reported earnings of -GBX 1.90 per share for Final. The report was announced on Wednesday, June 3, 2026.

The Biotech Growth Trust reported revenue of £430 thousand for Final.

The Biotech Growth Trust Earnings Headlines

The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 October 2026
Buy Stocks… A Crash is Coming
Think stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.tc pixel
The Biotech Growth Trust PLC - Total Voting Rights
(BIOGW) Biotech Growth Trust Plc
See More The Biotech Growth Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email.

About The Biotech Growth Trust

The Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

View The Biotech Growth Trust Profile